Novo Nordisk A/S Stock

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen 11:20:00 2024-06-24 EDT 5-day change 1st Jan Change
988.4 DKK +0.05% Intraday chart for Novo Nordisk A/S -0.26% +41.58%

Financials

Sales 2024 * 291B 41.91B 57.2B Sales 2025 * 352B 50.63B 69.09B Capitalization 4,384B 631B 861B
Net income 2024 * 105B 15.07B 20.56B Net income 2025 * 128B 18.38B 25.09B EV / Sales 2024 * 15.1 x
Net Debt 2024 * 22.09B 3.18B 4.34B Net cash position 2025 * 6.04B 869M 1.19B EV / Sales 2025 * 12.4 x
P/E ratio 2024 *
42.4 x
P/E ratio 2025 *
34.6 x
Employees 66,015
Yield 2024 *
1.2%
Yield 2025 *
1.47%
Free-Float 70.17%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.05%
1 week-0.26%
Current month+6.59%
1 month+5.44%
3 months+11.41%
6 months+42.20%
Current year+41.58%
More quotes
1 week
972.40
Extreme 972.4
995.80
1 month
906.40
Extreme 906.4
997.40
Current year
688.80
Extreme 688.8
997.40
1 year
504.40
Extreme 504.4
997.40
3 years
254.50
Extreme 254.5
997.40
5 years
156.00
Extreme 156
997.40
10 years
109.10
Extreme 109.1
997.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 90-12-31
Director of Finance/CFO 53 98-12-31
Chief Tech/Sci/R&D Officer - 15-09-30
Members of the board TitleAgeSince
Director/Board Member 62 15-03-18
Chairman 61 17-03-22
Director/Board Member 68 18-02-28
More insiders
Date Price Change Volume
24-06-24 988.4 +0.05% 1,647,250
24-06-21 987.9 -0.59% 4,624,522
24-06-20 993.8 +0.98% 1,892,064
24-06-19 984.2 +0.31% 1,225,962
24-06-18 981.2 +0.07% 2,019,980

Delayed Quote Nasdaq Copenhagen, June 24, 2024 at 11:20 am

More quotes
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
988.4 DKK
Average target price
934.3 DKK
Spread / Average Target
-5.48%
Consensus
  1. Stock Market
  2. Equities
  3. NOVO B Stock